Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
NANOPHASE TECHNOLOGIES Corp (NANX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
05/12/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "Nanophase Reports Record First Quarter Revenue for 2023 — Delivered over $9 Million in Q1 revenue — Progressive bottom line improvement through Q1 ROMEOVILLE, Ill., May 11, 2023 -- Nanophase Technologies Corporation , a leader in minerals-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced financial results for the first quarter ended March 31, 2023. Jess Jankowski, President and Chief Executive Officer, commented: “We are pleased to have ended the quarter with a strong March in terms of both revenue and profitability. Our Q1 results are not in line with our plan, with poor January performance proving difficult to overcome. However,..."
05/04/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "PROMISSORY NOTE"
03/29/2023 8-K Quarterly results
03/29/2023 10-K Annual Report for the period ended December 31, 2022
12/02/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Nanophase Reports Strong Revenue for Third Quarter as Growth Continues — Delivered $9.7 million in Q3 revenue     — In Beauty Science markets, Solésence revenue is up 39% YOY  — In Personal Care Ingredients markets, Nanophase revenue is up 61% YOY  ROMEOVILLE, Ill., Nov. 08, 2022 -- Nanophase Technologies Corporation , a leader in minerals-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced third quarter and nine-month 2022 financial results.  “Our Solésence revenues grew 39%, and our Active Pharmaceutical revenues grew 61% from 2021 to 2022, when comparing the nine-month periods ending Sept..."
08/17/2022 8-K Quarterly results
08/16/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/16/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/16/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/11/2022 8-K Quarterly results
03/31/2022 8-K Quarterly results
Docs: "Set Up For Strong Growth, Nanophase Reports Second Consecutive Year of Record Financial Results for 2021 as Solésence Continues to Lead and Personal Care Ingredients Category Thrives — Another record year with 70% YOY growth — Delivered $29 Million in full year revenue — In Beauty Science markets, Solésence revenue is up 170% YOY while Active Pharmaceutical Ingredients sales are up 40% — Acquired new facility space to support strategic growth and improve operational effectiveness — Closed on January 2022 financing to double borrowing capacity ROMEOVILLE, Ill., March 31, 2022 -- Nanophase Technologies Corporation , a leader in minerals-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggre..."
03/31/2022 10-K Annual Report for the period ended December 31, 2021
02/02/2022 8-K Quarterly results
01/14/2022 SC 13G/A Conley John Howard Jr reports a 3.7% stake in Nanophase Technologies Corp
12/23/2021 SC 13D/A WHITMORE BRADFORD T reports a 62.1% stake in Nanophase Technologies Corporation
12/09/2021 8-K Quarterly results
11/23/2021 DEF 14A Form DEF 14A - Other definitive proxy statements:
11/12/2021 PRE 14A Form PRE 14A - Other preliminary proxy statements:
11/04/2021 10-Q Quarterly Report for the period ended September 30, 2021
11/03/2021 8-K Quarterly results
Docs: "Nanophase Technologies Reports Record Financial Results for Third Quarter Ended September 30, 2021"
08/17/2021 8-K Quarterly results
08/16/2021 10-Q Quarterly Report for the period ended June 30, 2021
08/16/2021 10-Q/A Quarterly Report for the period ended March 31, 2021 [amend]
08/16/2021 8-K Quarterly results
06/14/2021 8-K Quarterly results
05/17/2021 10-Q Quarterly Report for the period ended March 31, 2021
04/27/2021 8-K Quarterly results
04/21/2021 8-K Quarterly results
04/20/2021 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy